Literature DB >> 12915160

The impact of total joint replacement in rheumatoid arthritis.

Rob G H H Nelissen1.   

Abstract

Management of the patient with rheumatoid arthritis (RA) requires a multidisciplinary approach, the role of the surgeon being to improve functional ability for the patient by reconstructing a deteriorated joint by total joint arthroplasty (TJA). An advantage of prosthetic evaluation over pharmacological medication evaluations is that the 'compliance' of the patient with the treatment (i.e. the TJA) is 100%, even at long-term follow-up. However, long-term follow-up of prosthesis evaluation is as difficult as the evaluation of any other intervention. Although the goal of any intervention on an RA patient is to improve functional ability, and thus self-support, of the patient, objective evaluation of the surgical procedure, and of its impact on the patient, can be difficult. The potential chronic course of RA makes evaluation of a specific surgical procedure and its effect on the patient difficult to interpret. The success of the TJA is generally judged on a survivorship analysis at 10 or 15 years in national registries (i.e. >40000 implants); revision surgery is used as an end-point for survival of the TJA. With a mean 90% survival at 10-year follow-up, total hip arthroplasty and total knee arthroplasty may be considered gold-standard TJA procedures for the patient. While revision is the end-point, the course to this end-point starts with progressive micromotion of the prosthesis. The effect of prosthetic changes, and of medication on prosthesis migration, can be measured very accurately by radiostereometry. The latter measures the actual performance of the TJA in the bone. Next to these more procedure-oriented evaluations, patient-oriented evaluations (e.g. quality of life, patient expectations) are of importance in judging the impact of the TJA on the RA patient. These evaluations provide evidence that the pre-operative status of the joint/extremity determines the extent of post-operative functional gain. Thus, postponing TJA for too long will give less functional benefit.

Entities:  

Mesh:

Year:  2003        PMID: 12915160     DOI: 10.1016/s1521-6942(03)00065-2

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  10 in total

1.  Cementless total hip arthroplasty in patients with rheumatoid arthritis using a tapered designed titanium hip stem minimum: 10-year results.

Authors:  Hans D Carl; Jan Ploetzner; Bernd Swoboda; Gerd Weseloh; Lutz Arne Mueller
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 2.631

2.  Comorbid conditions are associated with healthcare utilization, medical charges and mortality of patients with rheumatoid arthritis.

Authors:  Guang-Ming Han; Xiao-Feng Han
Journal:  Clin Rheumatol       Date:  2016-04-23       Impact factor: 2.980

3.  Functional Evaluation of Patients Undergoing Multiple Joint Replacements: A Retrospective Study of 50 Patients with a Minimum of Six Months of Follow-up.

Authors:  Shubhranshu S Mohanty; Nandan Mishra; Prateek Patil; Ajinkya Desale
Journal:  Cureus       Date:  2016-10-15

4.  Greek NHS capacity constraints regarding intravenous treatment for rheumatoid arthritis patients.

Authors:  Kostas Athanasakis; Marios Detsis; Kyriakos Souliotis; Christina Golna; John Kyriopoulos
Journal:  Rheumatol Int       Date:  2011-01-15       Impact factor: 2.631

5.  Cementless total knee arthroplasty in chronic inflammatory rheumatism.

Authors:  Jonathan Buchheit; Antoine Serre; Xavier Bouilloux; Marc Puyraveau; Laurent Jeunet; Patrick Garbuio
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-09-17

6.  The use of biologic DMARDs identifies rheumatoid arthritis patients with more optimistic expectations of total knee arthroplasty.

Authors:  Susan M Goodman; Lisa A Mandl; Mark Figgie; Beverly K Johnson; Michael Alexiades; Hassan Ghomrawi
Journal:  HSS J       Date:  2014-02-19

7.  Costs and outcomes of total hip and knee joint replacement for rheumatoid arthritis.

Authors:  L M March; A L Barcenilla; M J Cross; H M Lapsley; D Parker; P M Brooks
Journal:  Clin Rheumatol       Date:  2008-05-24       Impact factor: 2.980

8.  Rheumatoid arthritis vs osteoarthritis in patients receiving total knee arthroplasty: perioperative outcomes.

Authors:  Ottokar Stundner; Thomas Danninger; Ya-Lin Chiu; Xuming Sun; Susan M Goodman; Linda A Russell; Mark Figgie; Madhu Mazumdar; Stavros G Memtsoudis
Journal:  J Arthroplasty       Date:  2013-06-12       Impact factor: 4.757

9.  Patient-reported outcome after rheumatoid arthritis-related surgery in the lower extremities: a report from the Swedish National Register of Rheuma Surgery (RAKIR).

Authors:  Anna Clara Benoni; Ann Bremander; Anna Nilsdotter
Journal:  Acta Orthop       Date:  2011-12-29       Impact factor: 3.717

10.  Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data.

Authors:  Samuel Hawley; M Sanni Ali; René Cordtz; Lene Dreyer; Christopher J Edwards; Nigel K Arden; Cyrus Cooper; Andrew Judge; Kimme Hyrich; Daniel Prieto-Alhambra
Journal:  Rheumatology (Oxford)       Date:  2019-07-01       Impact factor: 7.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.